Shenzhen - Delayed Quote CNY
Amoy Diagnostics Co., Ltd. (300685.SZ)
21.20
+0.38
+(1.83%)
At close: 3:04:37 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,147,750.69
1,108,948.70
1,043,506.69
842,180.43
917,033.39
Cost of Revenue
177,835.46
169,145.10
167,293.96
147,810.50
143,274.71
Gross Profit
969,915.22
939,803.60
876,212.73
694,369.93
773,758.69
Operating Expense
640,501.25
634,218.52
579,016.19
524,250.72
508,898.93
Operating Income
329,413.97
305,585.08
297,196.54
170,119.21
264,859.76
Net Non Operating Interest Income Expense
31,998.88
24,887.42
17,600.77
4,709.53
2,329.91
Pretax Income
318,107.94
289,880.66
294,857.12
286,082.86
251,979.48
Tax Provision
36,971.78
35,017.22
33,372.69
21,790.71
12,954.98
Net Income Common Stockholders
281,136.16
254,863.44
261,484.43
263,743.02
239,573.62
Basic EPS
0.71
0.64
0.66
0.67
0.60
Diluted EPS
0.71
0.64
0.66
0.67
0.60
Basic Average Shares
396,251.98
398,224.13
396,188.54
393,646.30
399,289.37
Diluted Average Shares
396,251.98
398,224.13
396,188.54
393,646.30
399,289.37
Total Operating Income as Reported
320,113.23
292,977.98
301,246.72
287,662.63
253,238.34
Total Expenses
818,336.71
803,363.62
746,310.15
672,061.21
652,173.63
Net Income from Continuing & Discontinued Operation
281,136.16
254,863.44
261,484.43
263,743.02
239,573.62
Normalized Income
311,168.93
281,822.99
271,599.04
178,548.04
246,147.70
Interest Income
27,797.36
26,579.32
19,169.58
6,106.85
3,131.28
Interest Expense
1,368.59
1,339.20
1,195.08
993.05
375.16
Net Interest Income
31,998.88
24,887.42
17,600.77
4,709.53
2,329.91
EBIT
319,476.52
291,219.87
296,052.20
287,075.91
252,354.64
EBITDA
319,476.52
347,095.44
352,597.71
339,347.82
291,261.54
Reconciled Cost of Revenue
177,835.46
169,145.10
167,293.96
147,810.50
143,274.71
Reconciled Depreciation
--
55,875.58
56,545.51
52,271.91
38,906.90
Net Income from Continuing Operation Net Minority Interest
281,136.16
254,863.44
261,484.43
263,743.02
239,573.62
Total Unusual Items Excluding Goodwill
-33,982.33
-30,663.68
-11,405.51
92,219.25
-6,930.39
Total Unusual Items
-33,982.33
-30,663.68
-11,405.51
92,219.25
-6,930.39
Normalized EBITDA
353,458.86
377,759.12
364,003.23
247,128.57
298,191.93
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,949.56
-3,704.13
-1,290.91
7,024.27
-356.31
12/31/2021 - 8/3/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
603108.SS Shanghai Runda Medical Technology Co., Ltd.
18.99
+4.80%
300676.SZ BGI Genomics Co., Ltd.
49.43
+2.40%
3347.HK Hangzhou Tigermed Consulting Co., Ltd
27.350
+0.55%
603259.SS WuXi AppTec Co., Ltd.
60.34
+1.98%
2268.HK WuXi XDC Cayman Inc.
37.100
-4.26%
2359.HK WuXi AppTec Co., Ltd.
62.350
-3.18%
ILMN Illumina, Inc.
78.17
+0.37%